Pictet Asset Management
DGX icon

Pictet Asset Management’s Quest Diagnostics DGX Stock Holding History

Pictet Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7M Sell
69,234
-33,104
-32% -$6.5M 0.01% 608
2026
Q1 		$20.1M Sell
102,338
-59,915
-37% -$11.6M 0.02% 499
2025
Q4 		$28.2M Sell
162,253
-47,663
-23% -$8.68M 0.03% 443
2025
Q3 		$40M Sell
209,916
-109,543
-34% -$19.4M 0.04% 363
2025
Q2 		$57.4M Buy
319,459
+57,876
+22% +$10.1M 0.06% 299
2025
Q1 		$44.3M Sell
261,583
-39,646
-13% -$6.51M 0.05% 326
2024
Q4 		$45.4M Buy
301,229
+7,938
+3% +$1.23M 0.05% 319
2024
Q3 		$45.5M Buy
293,291
+2,598
+0.9% +$388K 0.05% 308
2024
Q2 		$39.8M Sell
290,693
-30,445
-9% -$4.17M 0.05% 322
2024
Q1 		$42.7M Sell
321,138
-236,096
-42% -$30.6M 0.05% 340
2023
Q4 		$76.8M Sell
557,234
-408,984
-42% -$53.8M 0.08% 243
2023
Q3 		$118M Buy
+966,218
New +$129M 0.15% 173

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Pictet Asset Management's DGX Position: Q2 2026 in Review

Pictet Asset Management reduced its Quest Diagnostics (DGX) stake by 32% in Q2 2026, selling an estimated $6.5M and leaving 69,234 shares worth $14.7M. The position accounts for 0.01% of the portfolio, ranked #608.

Pictet Asset Management first reported a position in DGX in Q3 2023 and has held it in 12 quarters since. The position peaked at $118M in Q3 2023. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Pictet Asset Management held 69,234 shares of Quest Diagnostics worth $14.7M as of Q2 2026.
  • Pictet Asset Management sold 33,104 Quest Diagnostics shares in Q2 2026, an estimated $6.5M.
  • Quest Diagnostics made up 0.01% of Pictet Asset Management's portfolio in Q2 2026, its #608 holding.
  • Pictet Asset Management first reported a position in Quest Diagnostics in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Quest Diagnostics position peaked at $118M in Q3 2023.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.